Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01859689

Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer

A Phase II Study of Targeted Brachytherapy for Low Risk Prostate Cancer Patients

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Jonsson Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This phase II trial studies how well internal radiation therapy works in treating patients with low-risk prostate cancer. Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells.

Detailed description

PRIMARY OBJECTIVES: I. To determine long term 5 year prostate specific cancer (PSA) biochemical control using the Phoenix definition of PSA nadir + 2 of targeted hemi-gland brachytherapy. SECONDARY OBJECTIVES: I. To assess acute and late toxicity outcomes following targeted brachytherapy according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v4.0. II. To determine changes from baseline in health-related quality of life indicators using the validated Expanded Prostate Cancer Index Composite (EPIC) questionnaire, International Index of Erectile Function (IIEF) questionnaire, and International Prostate Symptom Score (IPSS) questionnaire. III. To assess the potential value of multiparametric magnetic resonance imaging, including dynamic contrast enhancement perfusion imaging and diffusion tensor neurovascular tactographic imaging in predicting the development of equivocal disease (ED) following radiation treatment. OUTLINE: Patients undergo 3 fractions of image-guided high-dose rate (HDR) brachytherapy over 2 days. After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

Conditions

Interventions

TypeNameDescription
RADIATIONbrachytherapyUndergo image-guided HDR brachytherapy
RADIATIONimage-guided radiation therapyUndergo image-guided HDR brachytherapy
OTHERlaboratory biomarker analysisCorrelative studies

Timeline

Start date
2012-03-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2013-05-22
Last updated
2020-07-27

Source: ClinicalTrials.gov record NCT01859689. Inclusion in this directory is not an endorsement.